Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by Silly_meon Jan 23, 2010 1:17am
358 Views
Post# 16710889

Hey KerBer and Karead

Hey KerBer and Karead
KerBery you are not wrong about Karead's posts (I have been reading them from way back when we were all on the private board), if he is holding shares then he is the Head Cheerleader, when he is out we spouts nothing but doom and gloom.

I understand why he does it, he is hoping to profit from the swings, but it really undermines his overall credibility with regards validity of the analysis of his posts.  Same stock info is interpreted completely different when he holds shares as compared to when he is waiting for a pullback. Not exactly unbiased analysis.

I find it really annoying when two weeks ago the stock was poised for upward movement - fundamentals were solid and then after he sells his shares ("out at $1.13) the company is a dog?

karead please don't misunderstand me - I respect the fact that you have done tons of research and understand this company extremely well - what I don't appreciate are your blattant attempts to manipulate investor sentiment and potentially impact share price.

As a long term investor I am more interested in the big picture and the down stream potential of the company and am less interested in trying to make money on the swings - in truth because I am hopeless at timing the bottoms and tops. 

Karead indulge me by giving me your answer (opinion) to the following question- as truthfully as you can: 

The SP for HEM will be significanly higher 12 months from now.  Yes or NO.

Ciao
Bullboard Posts